Anergis And Virometix Collaborate On Fast-Acting Allergy Immunotherapy
Combining Synthetic Virus-Like Particles With Contiguous Overlapping Peptides
An ultra-fast-acting allergy immunotherapy to induce tolerance to house dust mites is being sought in a collaboration between two Swiss biotechs, Anergis and Virometix.
